← Back
Data updated: Mar 29, 2026
CHANGZHOU PHARM
CardiovascularInfectious Disease
Generics
CHANGZHOU PHARM is a generic drug manufacturer focused on Cardiovascular, Infectious Disease.
2016
Since
4
Drugs
-
Trials
211
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 67%
2 drugs
Infectious Disease 33%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Active (3)
Discontinued (1)
Company Info
- First Approval
- 2016-10-31
- Latest
- 2026-02-02
- Applications
- 5